Rockefeller Capital Management L.P. lessened its stake in The Cigna Group (NYSE:CI - Free Report) by 22.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 48,097 shares of the health services provider's stock after selling 13,628 shares during the quarter. Rockefeller Capital Management L.P.'s holdings in The Cigna Group were worth $13,306,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. TCTC Holdings LLC purchased a new stake in The Cigna Group during the 4th quarter worth $25,000. Collier Financial acquired a new position in shares of The Cigna Group in the fourth quarter worth about $32,000. ORG Wealth Partners LLC acquired a new stake in The Cigna Group during the 4th quarter valued at approximately $34,000. Compagnie Lombard Odier SCmA acquired a new position in The Cigna Group during the 4th quarter worth $37,000. Finally, Heck Capital Advisors LLC bought a new stake in shares of The Cigna Group in the 4th quarter worth about $53,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, insider Noelle K. Eder sold 9,944 shares of the firm's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $320.00, for a total value of $3,182,080.00. Following the transaction, the insider now directly owns 13,406 shares in the company, valued at approximately $4,289,920. This trade represents a 42.59 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 4,904 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the completion of the sale, the insider now directly owns 29,421 shares in the company, valued at approximately $9,065,198.52. This represents a 14.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,751 shares of company stock worth $13,603,991. Insiders own 0.70% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on CI. Mizuho lifted their target price on The Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Cantor Fitzgerald lifted their price target on The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a report on Thursday, March 20th. Truist Financial lifted their target price on The Cigna Group from $375.00 to $385.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Piper Sandler reaffirmed an "overweight" rating and issued a $348.00 price objective (down previously from $394.00) on shares of The Cigna Group in a report on Monday, February 3rd. Finally, Guggenheim assumed coverage on shares of The Cigna Group in a research report on Wednesday, April 9th. They set a "buy" rating and a $384.00 price target on the stock. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $373.56.
Get Our Latest Analysis on The Cigna Group
The Cigna Group Stock Down 1.1 %
NYSE:CI traded down $3.60 during trading hours on Monday, hitting $326.53. 229,190 shares of the company's stock traded hands, compared to its average volume of 1,688,658. The stock's fifty day moving average price is $315.87 and its two-hundred day moving average price is $310.53. The firm has a market cap of $89.36 billion, a P/E ratio of 26.71, a P/E/G ratio of 0.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.
The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the previous year, the business earned $6.79 earnings per share. On average, research analysts expect that The Cigna Group will post 29.77 earnings per share for the current fiscal year.
The Cigna Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 1.85%. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date was Wednesday, March 5th. The Cigna Group's payout ratio is currently 49.35%.
The Cigna Group Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More

Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.